Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
about
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in miceTargeting the indoleamine 2,3-dioxygenase pathway in cancerMetabolic regulation of regulatory T cell development and functionIndoleamine 2,3 dioxygenase in intestinal diseaseThe blockade of immune checkpoints in cancer immunotherapy1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activityIndoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityAn insight into the transcriptome of the digestive tract of the bloodsucking bug, Rhodnius prolixusImmunological Relevance of the Coevolution of IDO1 and AHRExpression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia.Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.Combination of physical activity, nutrition, or other metabolic factors and vaccine responsePeripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi.Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.Utility of kynurenic acid for non-invasive detection of metastatic spread to lymph nodes in non-small cell lung cancerHIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenaseUpregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activityHIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cellsExpression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.Challenges and future perspectives of T cell immunotherapy in cancerInhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitisAbatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis model.Recent developments on immunotherapy for brain cancer.Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouseHuman placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses.Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in miceIndoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.A defect in tryptophan catabolism impairs tolerance in nonobese diabetic miceIDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survivalPeripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study.
P2860
Q24288997-FB9BDF2C-7CFD-4866-81B9-46B88D3D9CADQ26775471-47B82F6D-BD7D-4A67-8A29-6233BB112374Q26852681-D45F11C8-1C8B-4C43-A5B3-AA633B949E63Q27025063-4ED4EF5F-05E1-4AB4-B3DD-3105F7AB130FQ27860852-EA224EAF-5827-4173-BFC6-A8914D0CE246Q27863347-7295518F-74CC-4F29-8372-4CD8736A9F06Q28509235-A117ADA6-7965-4728-A128-D2313467FCABQ28538555-A1DD75B9-E236-448C-984F-82965A6B6A0BQ28654567-C661C867-B5C4-4607-8B77-A7CCEA41DB6EQ30931726-27433233-97BF-4342-AFF2-C10A70A25C35Q31037929-13BC067D-C422-4097-ABA9-6DA04EFED56CQ33394889-B209DC8E-7C90-433F-A991-2383CDB57321Q33731047-F8128519-F15D-48C0-BD4F-1F747C5E2089Q33743826-C40BD435-DC3A-4070-B86E-990E54C92A21Q33751144-108D848F-8AC8-44EA-A0E0-2FFAC8624B59Q33766714-4AAAF93B-0CF4-4E06-921E-96BC05725734Q33895262-71F105BD-E667-4556-A869-1A9D1647AE00Q34364948-F6341E19-D4F6-446C-8344-91F70F4C1FEBQ34526556-CD3502A4-01A2-4A9B-ABBE-701FCBBD2D3AQ34550440-F6A4CE26-949D-42E9-B3B6-952CBAD5083FQ34657284-F9520581-ACFA-4510-A18F-99AEC34B4DB2Q34942871-B301CD70-E603-4EE8-8BB3-5A1EF7C4A9B0Q35000687-125D313D-E474-4280-9D82-F2BC3C7F781CQ35109049-7C4871D9-6B2E-4203-887F-6BA8CAE5D85BQ35248373-FA03041C-A62F-455D-A815-0ADFAFEF034FQ35370968-54971489-6B70-4E8C-9B18-D19A09CF24D6Q35605835-4F165ECA-6773-4FC8-B355-900493593DF2Q35751070-17342105-190D-4A8B-8C8C-D9FB6270E590Q35835489-87E8CC19-C072-42FE-9A2D-98CBB60099DAQ35843507-7E7FDA50-9E13-4D76-A145-D04971E210E0Q35848218-F5813DCE-7A76-458F-A116-080455F3C181Q35986133-0EA32C38-E1DC-46C8-93BE-C5EE3AED1FE3Q35992355-55389B6B-7581-4701-9E0B-EE3BA935BDECQ36016868-BAEB41B4-32D4-4AF7-80C0-F57A3A4F65D6Q36050055-99E77B2D-C699-4CFB-8674-E0D694030A05Q36190558-375A81F2-F8F2-4D8C-A997-2DCA1306D465Q36219738-1C9D56B0-5C1B-4F8B-A6A7-4D619263E53CQ36376640-19009EDE-193B-4C4C-9444-CD842BC799AEQ36405905-18C1BAD9-5249-48C7-AE56-A9B7BE231BD8Q36425407-0B7BFF54-E01A-467D-B5D3-3D754FBE2B21
P2860
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
@en
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
@nl
type
label
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
@en
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
@nl
prefLabel
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
@en
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
@nl
P2093
P1476
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses
@en
P2093
Andrew L Mellor
Derin B Keskin
Phillip Chandler
Theodore Johnson
P304
P356
10.4049/JIMMUNOL.168.8.3771
P407
P577
2002-04-01T00:00:00Z